TLS data
 

BioCommunique

Corporate Newsletter

 
 
Ferring accesses Evotec's integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates.

Evotec and Ferring Form Strategic Research Alliance in Reproductive Medicine and Women's Health

  • Fri Nov 09 20:28:00 GMT 2018
  • San Diego
  • Author Evotec and Ferring

Evotec AG and Ferring Pharmaceuticals (“Ferring”) announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions.

Evotec will apply its drug discovery platform to design novel, safe and efficacious treatments in partnership with Ferring. The multi-target, multi-year collaboration aims to deliver small molecule pre-clinical development (“PDC”) and investigational new drug (“IND”) ready candidates. As part of the alliance, Evotec is eligible for undisclosed research funding and milestones.

Dr Mario Polywka, Chief Operating Officer of Evotec, commented: “The integration of our industry-leading small molecule discovery and development platform with Ferring’s deep disease expertise in reproductive medicine and women’s health will create a powerful combination that we hope will create a difference for patients suffering from infertility and gynaecological disorders. We very much look forward to working with such an innovative partner.”

Per Falk, Chief Science Officer, Ferring, added: “To achieve leadership in reproductive medicine and women’s health, we are expanding beyond our historical expertise in peptides and tackling molecular targets that are best addressed using small molecule therapeutics. Evotec is a highly regarded company in this field, and this alliance offers the prospect of significant innovation for patients. Together, we have the potential to make a difference for both men and women who are struggling to start a family, and for women suffering from gynaecological conditions.”

 
 

Stay in the know with the Biocommunique

Sign up for Biocom's monthly newsletter to get all the latest life science news sent directly to your inbox.

 
 

Related Articles View All

https://www.biocom.org/servlet/servlet.ImageServer?id=0155A000009QUcWQAW&oid=00DA0000000Kz7JMAS  
Enhanced data exchange combined with advanced analytics are expected to reduce raw material variability
https://www.biocom.org/servlet/servlet.ImageServer?id=0155A000009QV2PQAW&oid=00DA0000000Kz7JMAS  
Check out the programs offered to you for career development through Northeastern University.
https://www.biocom.org/servlet/servlet.ImageServer?id=0155A000009QUbxQAG&oid=00DA0000000Kz7JMAS  
This year-long program is specifically geared towards early-stage professionals in medicine, engineering, design, and business.
https://www.biocom.org/servlet/servlet.ImageServer?id=0155A000009QTLyQAO&oid=00DA0000000Kz7JMAS  
Seed money is available for California Medical Device Manufacturers engaged in Cable and Wire Harnesses and PCBAs.